|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
289,870,000 |
Market
Cap: |
65.74(B) |
Last
Volume: |
1,691,719 |
Avg
Vol: |
1,407,619 |
52
Week Range: |
$225.07 - $283.59 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 224 |
Guru Rank Value : 5.4 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s business segments are: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
8,597 |
9,836 |
17,573 |
47,101 |
Total Sell Value |
$2,028,812 |
$2,316,830 |
$4,382,400 |
$12,101,842 |
Total People Sold |
3 |
3 |
6 |
8 |
Total Sell Transactions |
4 |
5 |
10 |
16 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Kaltenbach Patrick |
EVP & Pres Life Sciences |
|
2019-06-04 |
4 |
S |
$235.00 |
$64,625 |
D/D |
(275) |
16,207 |
|
- |
|
Kaltenbach Patrick |
EVP & Pres Life Sciences |
|
2019-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,379 |
16,482 |
|
- |
|
Kaltenbach Patrick |
EVP & Pres Life Sciences |
|
2019-06-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(292) |
4,103 |
|
- |
|
Khichi Samrat S. |
EVP and General Counsel |
|
2019-05-21 |
4 |
S |
$234.68 |
$3,774,828 |
D/D |
(16,085) |
12,608 |
|
- |
|
Larson Betty D |
EVP HR & CHRO |
|
2019-05-13 |
4 |
S |
$224.91 |
$382,447 |
D/D |
(1,700) |
8,843 |
|
- |
|
Larson Betty D |
EVP HR & CHRO |
|
2019-05-13 |
4 |
D |
$224.99 |
$213,741 |
D/D |
(950) |
10,543 |
|
- |
|
Larson Betty D |
EVP HR & CHRO |
|
2019-05-13 |
4 |
OE |
$97.14 |
$213,708 |
D/D |
2,200 |
11,493 |
|
- |
|
Burzik Catherine M |
Director |
|
2019-04-17 |
4 |
S |
$223.04 |
$10,037 |
D/D |
(45) |
10,007 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2019-04-16 |
4 |
GA |
$0.00 |
$0 |
D/D |
7,764 |
218,671 |
|
- |
|
Burzik Catherine M |
Director |
|
2019-04-16 |
4 |
B |
$247.96 |
$7,439 |
D/D |
30 |
10,052 |
2.39 |
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2019-03-15 |
4 |
S |
$255.13 |
$2,119,875 |
D/D |
(8,309) |
210,907 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2019-03-15 |
4 |
D |
$255.13 |
$885,046 |
D/D |
(3,469) |
219,216 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2019-03-15 |
4 |
OE |
$76.64 |
$910,330 |
D/D |
11,878 |
222,785 |
|
- |
|
Mas Ribo Alberto |
EVP and Pres, Life Sciences |
|
2019-03-15 |
4 |
S |
$255.00 |
$536,520 |
D/D |
(2,104) |
15,482 |
|
- |
|
Mas Ribo Alberto |
EVP and Pres, Life Sciences |
|
2019-03-15 |
4 |
D |
$255.00 |
$379,440 |
D/D |
(1,488) |
17,586 |
|
- |
|
Mas Ribo Alberto |
EVP and Pres, Life Sciences |
|
2019-03-15 |
4 |
OE |
$108.89 |
$379,264 |
D/D |
3,483 |
19,074 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2019-03-04 |
4 |
S |
$255.03 |
$796,459 |
D/D |
(3,123) |
210,907 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2019-03-04 |
4 |
D |
$255.03 |
$342,250 |
D/D |
(1,342) |
214,030 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2019-03-04 |
4 |
OE |
$76.64 |
$342,198 |
D/D |
4,465 |
215,372 |
|
- |
|
Mas Ribo Alberto |
EVP and Pres, Life Sciences |
|
2019-03-04 |
4 |
S |
$255.03 |
$1,226,184 |
D/D |
(4,808) |
15,591 |
|
- |
|
Mas Ribo Alberto |
EVP and Pres, Life Sciences |
|
2019-03-04 |
4 |
D |
$255.03 |
$529,697 |
D/D |
(2,077) |
20,399 |
|
- |
|
Mas Ribo Alberto |
EVP and Pres, Life Sciences |
|
2019-03-04 |
4 |
OE |
$108.89 |
$529,641 |
D/D |
4,864 |
22,476 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2019-02-25 |
4 |
S |
$250.40 |
$2,839,536 |
D/D |
(11,340) |
210,907 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2019-02-25 |
4 |
D |
$250.40 |
$1,252,751 |
D/D |
(5,003) |
222,247 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2019-02-25 |
4 |
OE |
$76.64 |
$1,252,528 |
D/D |
16,343 |
227,250 |
|
- |
|
863 Records found
|
|
Page 16 of 35 |
|
|